At Ironwood, we recognize the importance of transparency in our interactions with healthcare professionals. We believe that transparency is a cornerstone to building and maintaining trust in and with stakeholders in healthcare – and this is essential, as trust is a key component that supports our goals of creating medicines that make a difference for patients and building value to earn the continued support of our fellow shareholders. We are committed to transparency and accurate reporting of Physician Payments Sunshine Act data to the Centers for Medicare & Medicaid Services (CMS), and we strive to adhere to evolving industry standards in this area.

For your convenience, we have provided links to additional information below on the Physician Payments Sunshine Act, also referred to as “open payments” or “aggregate spend.”

If you are a healthcare professional and you have an inquiry regarding the Physician Payments Sunshine Act, please click here to access the Centers for Medicare & Medicaid Services (CMS) Open Payments website.

For information about registering on the CMS website, please click here.

A list of frequently asked questions about the Physician Payments Sunshine Act is available on the CMS website by clicking on this link: www.cms.gov/OpenPayments/FAQs/FAQs-openpayments.html.

The CMS Open Payments Customer Support Line Help Desk is also accessible via email at openpayments@cms.hhs.gov and via phone at 1-855-326-8366 (Monday through Friday, from 8:30 a.m. to 7:30 p.m. (ET), excluding federal holidays).

Copyright © 2019, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.